H. Schilter

Most-cited papers

1. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

   K. Maslowski, A. T. Vieira, A. Ng, J. Kranich +9 more

   2009Nature3,116 citations Open access

   Semantic Scholar

   Save

2. Therapeutic targets in lung tissue remodelling and fibrosis.

   Gang Liu, A. M. Philp, T. Corte, M. Travis +7 more

   2021Pharmacology and Therapeutics218 citations Open access

   Semantic Scholar

   Save

3. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis

   H. Schilter, A. Findlay, L. Perryman, T. Yow +12 more

   2018Journal of Cellular and Molecular Medicine103 citations Open access

   Semantic Scholar

   Save

4. Responses of Mouse Airway Epithelial Cells and Alveolar Macrophages to Virulent and Avirulent Strains of Influenza A Virus

   Michelle D. Tate, H. Schilter, A. Brooks, P. Reading

   2011Viral immunology76 citations

   Semantic Scholar

   Save

5. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration

   H. Schilter, A. Collison, R. C. Russo, J. Foot +6 more

   2015Respiratory Research55 citations Open access

   Semantic Scholar

   Save

6. PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo

   J. Foot, T. Yow, H. Schilter, A. Buson +7 more

   2013Journal of Pharmacology and Experimental Therapeutics48 citations

   Semantic Scholar

   Save

7. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-Like 2/3.

   A. Findlay, J. Foot, A. Buson, Mandar Deodhar +7 more

   2019Journal of Medicinal Chemistry46 citations Open access

   Semantic Scholar

   Save

8. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy

   S. Stangenberg, S. Saad, H. Schilter, Amgad A. Zaky +3 more

   2018Scientific Reports42 citations Open access

   Semantic Scholar

   Save

9. Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice

   M. Starkey, R. Kim, E. Beckett, H. Schilter +8 more

   2012PLoS ONE36 citations Open access

   Semantic Scholar

   Save

10. An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies

    A. Findlay, C. Turner, H. Schilter, Mandar Deodhar +13 more

    2021Clinical and Translational Medicine25 citations Open access

    Semantic Scholar

    Save

11. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.

    May Y. W. Wong, S. Saad, Jie Zhang, Simon Gross +6 more

    2014AJP - Renal Physiology20 citations

    Semantic Scholar

    Save

12. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.

    H. Schilter, Carmen Z. Cantemir-Stone, V. Leksa, A. Ohradanova-Repic +7 more

    2015Immunology Letters16 citations Open access

    Semantic Scholar

    Save

13. A novel SSAO inhibitor PXS-4728 A suppresses inflammation and fibrosis and improves lung function in experimental chronic obstructive pulmonary disease

    A. Jarnicki, H. Schilter, G. Liu, K. Wheeldon +5 more

    20168 citations

    Semantic Scholar

    Save

14. Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease

    Elias Glaros, J. Foot, Ben Rayner, H. Schilter +5 more

    2025Nature Communications7 citations Open access

    Semantic Scholar

    Save

15. Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy

    May Y. W. Wong, S. Saad, M. Wong, S. Stangenberg +5 more

    2020PLoS ONE5 citations Open access

    Semantic Scholar

    Save